MMP9 and cardiovascular disorder: Furthermore, since MMP9 and MMP2 possess both deleterious and beneficial effects, depending upon the time of the progression of the cardiovascular disease, the exact dose and timing for SDS3 administration should be carefully monitored in order to optimize the treatment and attenuate progression to HFrEF.